Quick Answer
BELITE BIO, INC reported Research And Development Expense of $45.38 million for the year ending 2025.
- BELITE BIO, INC showed an increase of +51.6% in Research And Development Expense from 2024 to 2025.
- This data is from BELITE BIO, INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), BELITE BIO, INC's Research And Development Expense has grown by 1,130.4%.
- Historical annual values: Fiscal year 2025: $45.38 million | Fiscal year 2024: $29.94 million | Fiscal year 2023: $24.84 million | Fiscal year 2022: $8.87 million | Fiscal year 2021: $7.42 million | Fiscal year 2020: $3.69 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: